Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Andrea C. Pichler"'
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Exhausted CD8+ T (Tex) cells are a distinct cell population that arise during persistent antigen exposure in the context of chronic infections and cancers. Although characterized by progressive loss of effector functions, high and sustained inhibitor
Externí odkaz:
https://doaj.org/article/de404e54c81543bb815902703c987024
Autor:
Stanislas Goriely, Marie-Véronique Joubert, Tobias Bald, Mark J. Smyth, Ludovic Martinet, Elena Morandi, Loïc Dupré, Laure Buisson, Nadège Carrié, Marianne Weulersse, Guillaume Gaud, Marie Le Moine, Thomas Gossye, Anne Dejean, Hervé Avet-Loiseau, Ashmitha Sundarrajan, Assia Asrir, Andrea C. Pichler, Michaël Pérès, Abdelhadi Saoudi, Alejandra Martinez, Julien Mazieres, Sahar Kassem, Elisa Brauns, Els Verhoeyen, Indrajit Das, Sabrina Maheo, Matthias Braun, Vera Pancaldi, Clara Maria Scarlata, Marine Cuisinier, Maha Ayyoub, Laura Do Souto, Lea Lemaitre, Arantxa Agesta, Camille Guillerey
Publikováno v:
Immunity, 53 (4
Immunity
Immunity, Elsevier, 2020, 53 (4), pp.824-839.e10. ⟨10.1016/j.immuni.2020.09.006⟩
Immunity, 2020, 53 (4), pp.824-839.e10. ⟨10.1016/j.immuni.2020.09.006⟩
Immunity
Immunity, Elsevier, 2020, 53 (4), pp.824-839.e10. ⟨10.1016/j.immuni.2020.09.006⟩
Immunity, 2020, 53 (4), pp.824-839.e10. ⟨10.1016/j.immuni.2020.09.006⟩
Through complementary approaches, involving cancer patients’ samples and relevant mouse tumor models, Weulersse et al. reveal that CD8 T cells in the tumor microenvironment lose expression of the activating receptor CD226 (DNAM-1) in a manner that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dfe5be6f45852b02f2ba60ac27610fa
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/316003
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/316003
Autor:
P. Leif Bergsagel, Marta Chesi, Mircea Lazar, Mika Casey, Yuan Yu, Kimberley Stannard, Heidi Harjunpää, Michele W.L. Teng, Kim Miles, Andrea C. Pichler, Slavica Vuckovic, Ludovic Martinet, Mark J. Smyth, Kyohei Nakamura, Gunter Hartel, Geoffrey R. Hill, Alina I. Doban, Deborah S. Barkauskas, Sophie Krumeich, Camille Guillerey, David D. Smith
Publikováno v:
JCI Insight, 4(14):e125932. American Society for Clinical Investigation (ASCI)
Immunotherapy holds promise for patients with multiple myeloma (MM), but little is known about how MM-induced immunosuppression influences response to therapy. Here, we investigated the impact of disease progression on immunotherapy efficacy in the V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eef026619c8c7266b010a861d247e2d
https://pubmed.ncbi.nlm.nih.gov/31194697
https://pubmed.ncbi.nlm.nih.gov/31194697